0.67
-0.0079(-1.17%)
Currency In USD
| Previous Close | 0.68 |
| Open | 0.67 |
| Day High | 0.69 |
| Day Low | 0.65 |
| 52-Week High | 7.19 |
| 52-Week Low | 0.37 |
| Volume | 28,158 |
| Average Volume | 4.86M |
| Market Cap | 2.5M |
| PE | -0.16 |
| EPS | -4.08 |
| Moving Average 50 Days | 0.65 |
| Moving Average 200 Days | 1.04 |
| Change | -0.01 |
If you invested $1000 in Helius Medical Technologies, Inc. (HSDT) 10 years ago, it would be worth $0.03 as of February 05, 2025 at a share price of $0.67. Whereas If you bought $1000 worth of Helius Medical Technologies, Inc. (HSDT) shares 5 years ago, it would be worth $0.36 as of February 05, 2025 at a share price of $0.67.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study
GlobeNewswire Inc.
Jan 22, 2025 12:00 PM GMT
--PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people with Multiple Sclerosis-- --Statistically significant findings in DGI (Dynamic Gait Index) d
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market
GlobeNewswire Inc.
Jan 22, 2025 1:00 AM GMT
NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
GlobeNewswire Inc.
Jan 21, 2025 12:00 PM GMT
--128 enrolled participants, as of December 31, 2024, exceeds initial target of 90 participants-- --150 maximum participant enrollment projected by end of January-- --The stroke registrational program is intended to demonstrate the safety and effecti